FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 07:11:07 2024-05-23 am EDT | ||
| 7.03 EUR | -1.40% |
|
| Current month | +10.71% | ||
| 1 month | +47.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 7.03 | -1.40% |
| 24-05-22 | 7.13 | +0.14% |
| 24-05-21 | 7.12 | +7.23% |
| 24-05-20 | 6.64 | +4.40% |
| 24-05-17 | 6.36 | +1.27% |
Delayed Quote Deutsche Boerse AG
Last update May 23, 2024 at 07:11 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB0QT0 |
| ISIN | DE000SB0QT04 |
| Date issued | 2020-06-04 |
| Strike | 60.62 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.67 € |
|---|---|
| Lowest since issue | 1.47 € |
| Spread | 0.09 € |
| Spread % | 1.25% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.34
USD
Average target price
53.19
USD
Spread / Average Target
+25.64%
- Stock Market
- Certificates
- Certificat
